Erin Catherine Carter's most recent trade in GlucoTrack Inc was a trade of 40,297 Common Stock, par value $0.001 per share done . Disclosure was reported to the exchange on Dec. 31, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
GlucoTrack Inc | Erin Catherine Carter | Director | 31 Dec 2023 | 40,297 | 43,736 | - | 0 | Common Stock, par value $0.001 per share | ||
GlucoTrack Inc | Erin Catherine Carter | Director | 31 Dec 2023 | 2,078 | 3,439 | - | 31.2 | 64,834 | Common Stock, par value $0.001 per share | |
GlucoTrack Inc | Erin Catherine Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 2,078 | 2,078 | - | - | Series A Common Warrant | |
GlucoTrack Inc | Erin Catherine Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 2,078 | 2,078 | - | - | Series B Common Warrant | |
GlucoTrack Inc | Erin Catherine Carter | Director | 31 Dec 2023 | 2,078 | 0 | - | - | Series B Common Warrant | ||
GlucoTrack Inc | Erin Catherine Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 1,896 | 45,632 | - | 0 | Common Stock, par value $0.001 per share | |
GlucoTrack Inc | Erin Catherine Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 903 | 903 | - | 0 | Common Stock, par value $0.001 per share | |
GlucoTrack Inc | Erin Catherine Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 458 | 1,361 | - | 0 | Common Stock, par value $0.001 per share |